Correspondence: Bioaerosol Lung Damage: Trout's Response by Trout, DB
Comments on “Bioaerosol Lung
Damage in a Worker with
Repeated Exposure to Fungi in a
Water-Damaged Building” 
In their case report of a worker with lung
damage associated with microbial exposure,
Trout et al. (1) emphasized the need for
further research on markers of exposure to
bioaerosols, particularly fungi that produce
mycotoxins. The authors presented an
interesting pilot serologic investigation for
IgG and IgM antibodies to roridin (a
macrocyclic trichothecene mycotoxin pro-
duced by Stachybotrys chartarum) and
found no elevation of antibodies in the
index case, an individual with repeated
exposure to a water-damaged building. The
clinical evaluation of the index case did not
reveal elevation of IgG or IgE responses to
S. chartarum, although precipitating anti-
bodies were reportedly positive “only to
Thermoactinomyces vulgaris.” 
Although the environmental evaluation
and subsequent discussion on bioaerosols
focuses on fungi (particularly S. chartarum)
and mycotoxins, Trout et al. (1) did not
discuss the role that inhaled bacterial anti-
gens may have played in this individual’s
illness. This is perplexing, as inhalation
exposure to T. vulgaris is listed as one of
the most frequent causes of hypersensitivity
pneumonitis by Cormier (2), who was
cited by Trout et al. (1). Similar to fungi,
actinomycetes can grow on building mate-
rials in wet and warm places, and spread
their spores into the air (3).
The pulmonary and immunologic
effects of repeated exposure to T. vulgaris
have been studied in animal models (4),
and the clinical relevance of elevated and
repeated serologic testing of IgG and IgA
for T. vulgaris has been described after
human exposures in agricultural settings
(5). In a more recent EHP Grand Rounds
article describing a case of hypersensitivity
pneumonitis from residential exposure, the
presence of another clinically significant
thermophilic bacteria (Saccharopolyspora
rectivirgula) was documented in a water-
damaged home, and precipitating antibod-
ies to this organism were present in the
affected individual (6).
Although I acknowledge the impor-
tance of reducing or preventing exposure to
bioaerosols in the indoor environment as
well as the need for reliable biomarkers of
exposure, limiting the extent of the report-
ed investigation and discussion in this case
to fungi and mycotoxins seems unjustified.
It would be helpful if Trout et al. (1) could
further discuss the results of the serologic
testing with respect to T. vulgaris and if the
environmental assessment of bioaerosol
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Bioaerosol Lung Damage:
Trout’s Response
In his letter referring to our recent paper in
EHP (1), Sudakin points out that hypersensi-
tivity lung diseases have been shown to be
associated with exposure to thermophilic
actinomycetes such as Thermoactinomyces
vulgaris. Exposures to these organisms related
to lung disease have been reported in both
outdoor settings (when handling materials
such as compost or decomposing organic
matter—the classic example being farmer’s
lung) and indoor settings (2). Regarding the
indoor environment, reported exposures to
thermophilic organisms that cause docu-
mented hypersensitivity lung disease have
occurred in situations involving contamina-
tion of air-handling systems, primarily heat-
ing and/or humidification systems (3–7).
Thermophilic fungi (thermophiles) grow
optimally at temperatures between 35° and
50°C (95°–122°F) or hotter. In contrast,
most fungi are considered mesophiles, grow-
ing optimally between 15° and 30°C
(59°–86°F) (8).
Precipitating antibodies indicate expo-
sure to a substance and may provide sup-
porting evidence for a specific etiologic
exposure; these tests do not independently
prove or disprove a diagnosis of hypersensi-
tivity lung disease (9). Although the pres-
ence of precipitating antibodies can provide
justification for environmental evaluation of
exposure to specific antigens (10), the results
of precipitin testing must be interpreted
with knowledge of potential occupational
and/or environmental exposures experienced
by the patient. One of the limitations of
these antibody tests is that a single test that
indicates the presence of precipitating anti-
bodies does not provide any information
concerning the source of the antigens to
which the person was exposed.
The primary problem in the building of
concern in our report around the time of the
patient’s illness (and our evaluation) was
large-scale water incursion allowing for mas-
sive fungal contamination of building mate-
rials in multiple areas of the building. These
types of environmental conditions are not
conditions in which thermophiles would be
expected to grow well. As is commonly
found in hotels, each room of the building in
question had a dedicated unit ventilator to
condition the occupied space. Inspection of
selected unit ventilators in the building at the
time of our evaluation revealed no obvious
reservoirs of microbial growth. In addition,
our evaluation, and the illness experienced by
the patient in our report, took place during
the cooling season when heating units would
not routinely be in use. 
Given the above and the activities of
the patient likely leading to aerosolization
of the fungal contamination, there is no
reason to believe exposure to thermophilic
organisms played a role in this patient’s
building-related illness. It is unlikely that
an environmental evaluation for ther-
mophilic organisms in the areas that were
grossly contaminated with fungi would
have provided any useful information
regarding the illness experienced by the
patient discussed in our report. Additional
discussion of the potential role of ther-
mophilic organisms in the etiology of
hypersensitivity lung diseases in general was
beyond the scope of our paper. 
Douglas B. Trout
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Correction: Exposure
Measurement Error in
Time–Series Air Pollution Studies 
David Mage pointed out an error in the
first complete paragraph in the second col-
umn of page 423 in our paper “Exposure
Measurement Error in Time–Series
Studies of Air Pollution: Concepts and
Consequences” (1). This section contains a
brief analysis of the role of pollution origi-
nating from indoor and outdoor sources
that is incorrect in its derivation but correct
in its basic finding that average personal
exposure is roughly proportional to ambient
concentration. Hence, regression models
that use ambient measurements to predict
mortality can give different estimates of pol-
lution relative risks than would be obtained
if average personal exposure were available.
As we show (1), however, the corresponding
coefficient for personal exposure can be
obtained from the coefficient for ambient
concentration by a simple rescaling.
Below is a corrected analysis that depends
on the following definitions: zt* = ambient
concentration on day t; Iit = concentration
from indoor sources for person i on day t;
δit = proportion of pollutant of ambient
origin that penetrates indoors for person i
on day t; and pit = proportion of time spent
outdoors by person i on day t. 
The personal exposure for person i on
day t is given by 
xit = pit zt* + (1 – pit) {Iit + δit zt*}
= qit zt* + Jit,
where qit = pit + (1 – pit)δit is the fraction of
ambient concentration to which a person is
exposed on a given day by either being out-
doors or by being indoors and being
exposed to ambient pollution which has
penetrated indoors; and Jit = (1– pit)Iit is
the effective concentration of pollution
originating from indoor sources to which
person i is exposed on day t. 
If we average the equation above across
all people in a given region, we have that 
– xt = – qtzt* + – Jt.
Thus, the average personal exposure is linear-
ly related to the true ambient concentration
with slope coefficient – qt, the average of qit
across people. Here – Jt is the average concen-
tration of pollution from indoor sources to
which the population is exposed on day t. 
If we further assume that conditional on
weather, season and other adjustment vari-
ables in the time-series models, – Jt is roughly
independent of the ambient level zt*, this
equation shows that using ambient concen-
tration zt * to predict daily mortality will pro-
duce a regression coefficient that differs
from what would have been obtained using
mean personal exposure – xt by a multiplica-
tive factor that is roughly – q, the average of
the – qts over time. Note that – q is the fraction
of outdoor pollution to which the popula-
tion is on average exposed, either outdoors
or via penetration indoors. There is no fur-
ther bias introduced by – Jt because this is an
example of Berkson rather than classical
measurement error as described above.
In the United States, the average pro-
portion of time spent outdoors tends to be
small, so that – qt is to first approximation,
equal to the average percentage of ambient
concentration that penetrates indoors – δt. If
nearly all small particles penetrate indoors,
then – δt ≈ 1 and average personal exposure
will equal the ambient level plus the contri-
bution of indoor sources. Again if – Jt is
roughly independent of the ambient level
zt*, then regressing on ambient levels will
give similar results to regressing on average
personal exposure for small particles most
of which penetrate indoors. 
In the original paper, the equation above
mistook – qt to be the average fraction of total
exposure that originates outdoors; the cor-
rect analysis here shows that it is the average
ambient fraction of ambient pollution con-
centration to which a person is exposed
while outdoors (100%) and indoors
(100δ%). In addition, the original article
identified – Jt as the average concentration of
particles originating indoors. It is in fact the
average of the concentration originating
indoors to which persons are exposed and
therefore includes a term representing the
fraction of time persons spend indoors as
well as the pollutant level there. 
Scott L. Zeger 
Peter J. Diggle
Johns Hopkins University
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Confirmation of Uterotrophic
Activity for 4-MBC in the
Immature Rat
Schlumpf et al. (1,2) reported that the ultra-
violet (UV) sunscreen component 3-(4-
methylbenzylidine)camphor (4-MBC) is
uterotrophic when administered either in
diet to immature Long-Evans rats or by
whole body immersion of immature hairless
hr/hr rats into an oil solution of 4-MBC.
Subsequently, Bolt et al. (3) questioned the
validity of those data and referred to two neg-
ative unpublished immature rat uterotrophic
assays of 4-MBC (4,5). 
When the discussion between Bolt et al.
(3) and Schlumpf et al. (6) appeared, we had
already studied the uterotrophic activity of
4-MBC in immature rat uterotrophic assays
using both oral gavage and subcutaneous
injection as the route of administration. The
report on these studies has been submitted
for publication (7). Of particular relevance
to the recent discussion (3,6), we found 4-
MBC to be clearly positive in our standard
immature rat uterotrophic assay (8). Activity
was apparent in the oral study at 500 and
800 mg/kg/day and in the subcutaneous
injection study at 500 and 1,000 mg/kg/day.
In the oral gavage study (7), uterine weights
were 22.0 ± 2.5 for controls and 32.5 ± 6.5
and 42.4 ± 6.0 for 500 and 800 mg/kg
4-MBC, respectively (mean ± SD; p < 0.01
by analysis of variance and analysis of covari-
ance with terminal body weight).
John Ashby
Syngenta Central Toxicology Laboratory
Alderley Park, Cheshire, United Kingdom
E-mail: john.ashby@syngenta.com
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